食管癌后程加速超分割放疗疗效观察  被引量:3

Clinical reseouch of routine radiotherapy and late-course accelearted hyperfraction radiotherapy to treat esophageal corcinoma

在线阅读下载全文

作  者:翁川 李延军[1] 黄璐[1] 杜朝廷 

机构地区:[1]安康市人民医院放疗中心,陕西安康725000

出  处:《现代肿瘤医学》2009年第8期1474-1475,共2页Journal of Modern Oncology

摘  要:目的:探讨后程加速超分割放射治疗食管癌的疗效。方法:120例食管癌患者分为常规放射治疗组和后程加速超分割组(LCAF),加速组先常规放疗,前后对穿照射40Gy/20次(1次/d,2Gy/次,5次/周),而后复查食管X线片,在模拟机下定位后治疗,剂量为30Gy/20次(1.5Gy/次,2次/d,间隔6-8h,10次/周),2周完成。总剂量:70Gy/40次/6周。比较两种方法治疗效果及不良反应和并发症。结果:常规放射治疗组和LCAF组1年、2年、3年局控率分别为41.7%、28.3%、21.7%和66.7%、51.7%、46.7%(P<0.01)。1年、2年、3年生存率分别为46.7%、30%、20%和71.7%、58.3%、46.7%(P<0.01)。食管炎、气管炎、食管狭窄分别为18.3%、16.7%、3.3%和21.7%、21.7%、5%(P>0.05)。结论:后程加速超分割放射治疗食管癌的疗效比常规放射治疗提高了近1倍,虽然急性放疗反应有所增加,但患者均可耐受。Objective:To discuss the effect in treatment of esophageal carcinoma by late - course accelerated hyperfractionation radiotherapy. Methods:Total of 120 cases were divided into two groups, one group was treated by routine radiotherapy and another firstly treated by routine division which was AP - PAt portals irradiation 40Gy for 20 times,once everyday,2Gy every time, 5 times every week, and then located by analog machine and irradiated by 2 times every day,1.5Gy every time,with 6 -g hours interval, 10 times every week,30Gy for 20 times within two weeks. The total dose was 70Gy 40 times 6 weeks. Results: The routine radiotherapy group and LCAP group local control rates of one year,two year and three year were respectively 41.7% ,28, 3% ,21.7% and 66.7% ,51.7%, 46.7% (P 〈 0.01 ). The survival rates of one year, two year and three year were respectively 46.7% ,30% ,20% and 71.7% ,58.3% ,46.7% (P 〈0.01 ). The esophagitis, tracheitis and esophageal stenosis develop rates were respectively 18.3 %, 16.7%, 3.3 % and 21.7 % ,21.7% ,5 % ( P 〉 0.05 ). Conclusion: The effect of late - course accelerated hyperfractionation for esophageal carcinoma treatment is higher than the routine radiotherapy, although acute radiotherapy reaction, which is acceptable, will increase.

关 键 词:食管癌 后程加速超分割 放射治疗 

分 类 号:R735.1[医药卫生—肿瘤]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象